Founder and Managing Director of klausrose Consulting, Riehen, Switzerland

Size: px
Start display at page:

Download "Founder and Managing Director of klausrose Consulting, Riehen, Switzerland"

Transcription

1 Curriculum Vitae Dr. med. Klaus Rose (MD, MS) Current Address klausrose Consulting Pediatric Drug Development & More Aeussere Baselstrasse Riehen Switzerland Phone Mobile Personal Data Born 2 nd November 1953 in Heidelberg, Germany Nationality: German Married, two daughters Current Position Founder and Managing Director of klausrose Consulting, Riehen, Switzerland Education and Qualifications 2004 Master s Certificate in Project Management, The George Washington University School of Business, Washington D.C., USA 2000 Equivalence Certificate to Swiss Postgraduate Degree (FMH) in Pharmaceutical Medicine 1999 Diploma European Course Pharmaceutical Medicine (ECPM) 1992 German Postgraduate Degree in General Medicine Postgraduate clinical training in General Medicine in Germany and England (pediatrics, psychosomatic medicine, internal medicine, surgery, geriatrics) Study of Medicine in Berlin, Thesis in Medicine Study of Latin Languages & Psychology in Heidelberg and Berlin, MS in Psychology Employment History March 2011 today Managing Director, klausrose Consulting, Riehen, Switzerland March 2011 Principal Consultant at Granzer Regulatory Consulting, Munich, Germany Global Head Pediatrics, F.Hoffmann-La Roche Pharmaceuticals, Basel, Switzerland Novartis Pharmaceuticals, Switzerland Global Head Pediatrics - 1 -

2 Head, Special Projects, Clin Dev & Medical Affairs Senior International Medical Advisor, Basel (HQ) Medical Advisor in Bern (Swiss affiliate) 1996 Medical Director Lohman Medical, Neuwied, Germany Clinical Research Associate, Byk Gulden Pharmaceuticals, Germany (today: Takeda); in parallel: Medical Director, Byk AG, Switzerland Postgraduate clinical training in General Medicine in Germany and England (pediatrics, psychosomatic medicine, internal medicine, surgery, medicine for the elderly) Other Professional Activities: Regular speaker on international confererences on pediatric drug development; member of EFGCP, DIA, AAAS, ESDP, facultuy member of several institutions that train in drug development and clinical research (ECPM, FORUM, ECCRT, others) Leadership in International Institutions 1/2005 to 12/2014 Chairman, EFGCP Children s Medicines Working Party Chairman, DIA Pediatric SIAC 8/ /2009 Chairman, IFPMA ( Pediatric Task Force Professional Experience After clinical training started in Byk Gulden, Konstanz, Germany (today: Takeda) as a clinical trial physician. Run two phase 1 trials and several large international pantoprazole phase 3 trials in Europe and Latin America. Worked in parallel at Byk Gulden Switzerland as Medical Director. Trained the sales representatives in gastroeneterology (pantoprazole), pneumology (theophyllin), cardiovascular diseases (omega-3-oil capsules), and other areas. Worked ½ year in Lohman Medical Devices in Germany, buildung up the fundaments of a medical affairs team. Worked in Bern, Switzerland with Novartis Switzerland as a clinical trial physician in the areas of oncology, dermatology, pneumology, gastroenterology and central nervous system. When promoted to Novartis Headquarter in Basel, Switzerland, as Senior International Medical Advisor, built up the international Medical Communication function which eventually became an own department. Furthermore, established the cross-functional Pediatric Advisory Group (PAG) in 2000 to improve the company s capabilities in handling the US American pediatric legislation, including 6 months Pediatric Exclusivity (patent prolongation). Advised teams in building pediatric development plans across all development functions (preclinical toxicology & safety; galenic formulations; modelling & simulation (M&S) / Clinical Pharmacology; Clinical Development; Post-Marketing Commitments) and across all indication areas (oncology, cardiovascular diseases, dermatology, respiratory diseases, Central Nervous System, others). Was involved with the Xolair team in the preparation of the pediatric strategy. Established a network within the top twenty pharmaceutical companies to drive cooperation in pediatric drug development and established the annual EFGCP pediatric conference together with colleagues from other companies, academia, and from regulatory authorities from EU national countries and the European Medicines Agency. This conferences was later merged with the DIA pediatric conference and is continuing until today

3 With the move to Roche in 2005 established the Roche Pediatric Group as cross-functional pediatric drug development structure and worked with teams across all development functions and indication areas (inflammatory diseases, nephrology, oncology, others). Started to advise teams and work with them on EMA / PDCO (pediatric committee) pediatric investigation plans (PIPs) when the EU pediatric regulation came into force in Established together with a colleague from GlaxoSmith Cline the pediatric taskforce of the IFPMA (International Federation of Pharmaceutical Industries and Associations), serving as chairman. Co-chairman was a colleague from Pfizer. With the move to Granzer Regulatory Consulting in 2010 responsible for hands-on preparation, writing, submission & negotiation of PIPs with the EMA / PDCO. Sucessfully concluded 8 PIPs from scratch to final acceptance by EMA. With establishing an own company, started to advise US & EU based companies on strategies in handling FDA & EU regulatory pediatric requirements. Continued to chair the EFGCP Children s Medicines Working Party and as such member in the organizing committee of the EFGCP/DIA/EMA annual conference on Pediatric Drug Development which in 2012 was held September 26/27 in London, UK. Also continued international network in pediatric drug development resulting in numerous presentations on international conferences. Leadership Skills Most responsabilities were performed in a matrix structure coordinating with up to 25 people in general issues of pediatric drug development both in Novartis and Roche. Pediatrics was usually 10 20% of coordinated persons KPI s which had to be evaluated annually. Maximum number of direct reports was 5 in a Roche taskforce. Publications Rose K & Kummer H: A New Ethical Challenge for Institutional Review Boards (IRBs)/Ethics Committees (ECs) in the Assessment of Pediatric Clinical Trials. Children 2015, 2, Rose K & Spigarelli MG: Cystic Fibrosis Treatment: A Paradigm for New Pediatric Medicines, Globalization of Drug Development and the Role of the European Medicines Agency. Children 2015, 2, ; Rose K & Senn S: Drug development: EU paediatric legislation, the European Medicines Agency and its Paediatric Committee adolescents melanoma as a paradigm. Pharmaceutical Statistics 2014; 13(4): Rose K: The Vision of Better Medicines for Children and the Role of Regulatory Authorities. Pharmaceutical Regulatory Affairs 2014; 3:2 better-medicines-for-children-and-the-role-of-regulatory-authorities e127.pdf Rose K: European Union Pediatric Legislation Jeopardizes Worldwide, Timely Future Advances in the Care of Children With Cancer. Clinical Therapeutics 2014, 36 (2),

4 Bar-Shalom D & Rose K: Pediatric Formulations A Roadmap (Textbook). AAPS & Springer, ISBN: Bar-Shalom D & Rose K: Pediatric Formulations A Roadmap (Textbook), preface: free Rose K: Clinical Testing in Children. In: Bar-Shalom D & Rose K: Pediatric Formulations A Roadmap, AAPS & Springer, 2014: chapter 25, pp Rose K: Pediatric Pharmaceutical Legislation in the USA and EU and Their Impact on Adult and Pediatric Drug Development. In: Bar-Shalom D & Rose K: Pediatric Formulations A Roadmap, AAPS & Springer, 2014: chapter 28, pp Klaus Rose: A Paediatric Investigation Plan Case Study. Pharm Med 2012; 26 (5): Klaus Rose: Pediatric Drug Development. A Closing Thought. Applied Clinical Trials 2012; 21 (11), 50 Klaus Rose: Impact of EU & US Pediatric Legislation on Industry, Authorities & Academia. American Pharmaceutical Review, online, December 2011 Klaus Rose & Oscar della Pasqua: Development of Paediatric Medicines: Concepts and Principles. in Seyberth, HW. Rane A, Schwab M (Eds.): Pediatric Clinical Pharmacology (Handbook of Experimental Pharmacology Vol. 205), Springer, September 2011 Rose, K. (2011): The value of juvenile animal studies: a pediatric clinical perspective. Birth Defects Research Part B: Developmental and Reproductive Toxicology 2011; 92 (4), Klaus Rose & John van den Anker (Editors): Guide to Paediatric Drug Development and Clinical Research. Karger, May 2010, ISBN-10: , ISBN-13: Irina Staatz & Klaus Rose: Paediatric Legislation A Potential Roadblock to New Drugs in Europe. Business Development & Licensing Journal ( issue 11, January 2010 Klaus Rose: Grosse Anstrengungen für die Kleinen. VSAO Journal 6 / 2009, Klaus Rose: Challenges in Pediatric Drug Development. A Pharmaceutical Industry Perspective. Pediatr Drugs 2009; 11 (1): Klaus Rose: Ethical Principles of Pediatric Research and Drug Development. Chapter 11 in: Pediatric Drug Development Concepts and Applications. Mulberg AE, Silber SA & van den Anker, JN (Editors), Wiley-Blackwell, 2009 Klaus Rose: European Perspectives. Chapter 13 in: Pediatric Drug Development Concepts and Applications. Mulberg AE, Silber SA & van den Anker, JN (Editors), Wiley-Blackwell, 2009 Klaus Rose: Ethical, Regulatory and Scientific Challenges in Paediatric Drug Development. Pharm Med 2008; 22 (4): Sergio G. Golombek, John van den Anker, & Klaus Rose: Clinical Trials in Children. Ethical and Practical Issues. Int J Pharm Med 2007; 21 (2): Klaus Rose & John van den Anker (Editors): Guide to Paediatric Clinical Research. Karger 2007; ISBN-10: / ISBN-13:

5 Klaus Rose: Integration of pediatric aspects into the general drug development process Ernst Schering Res Found Workshop. 2007;(59): Klaus Rose : Which industry-sponsored pediatric research programs can be expected to be triggered by the EU pediatric regulation? Standardy Medyczne 2005; 5: Klaus Rose: European Draft Pediatric Regulation and Challenges in Pediatric Drug Development: Jap J Clin Pharmacol & Ther 2005;18 (1) 9-14 Klaus Rose: Better medicines for children where are we now, and where do we want to be? Br J Clin Pharmacol. 2005; 59(6): Languages Fluent in German, English, Spanish, Italian, French. Basics in Portuguese, Greek and Hungarian. Private interests Family, Classical Guitar, Latin Culture, Cooking, Gardening Riehen, October 2015 Klaus Rose - 5 -

CURRICULUM VITAE. 1231 Conches (Swtzerland) 0041-76-316.10.38 (personal assistant) Private phone number 0041-22-830.15.45

CURRICULUM VITAE. 1231 Conches (Swtzerland) 0041-76-316.10.38 (personal assistant) Private phone number 0041-22-830.15.45 1Curriculum vitae F.A. Waldvogel, M.D. 1 CURRICULUM VITAE WALDVOGEL Francis A. Origin Geneva (Switzerland) Date of birth October 19, 1938 Languages French, German, English (fluent) Italian (good understanding)

More information

Regulatory Affairs Graduate & Postgraduate Program. Novartis Pharma AG Novartis Animal Health AG

Regulatory Affairs Graduate & Postgraduate Program. Novartis Pharma AG Novartis Animal Health AG Regulatory Affairs Graduate Postgraduate Program Novartis Pharma AG Novartis Animal Health AG The Regulatory Affairs (RA) Graduate Program is an opportunity to discover the global functions of Drug Regulatory

More information

European Forum for Good Clinical Practice. 26 November 2008 - Management Centre Europe, Brussels, Belgium. Children s Medicines Working Party

European Forum for Good Clinical Practice. 26 November 2008 - Management Centre Europe, Brussels, Belgium. Children s Medicines Working Party Programme Version 19 November 2008 The EFGCP Children s Medicines Working Party 4 th Annual Conference EU & US Paediatric Legislation: What is Changing in Practice in Paediatric Drug Treatment, Research

More information

Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV

Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV Enabling Discovery, Development, and translation of treatments for Cognitive Dysfunctions in Depression: A Workshop Session IV Maria Isaac, MASc, MD, PhD, MFPM, Psychiatrist Senior Scientific Officer Institute

More information

PEDIATRIC MEDICINES: GLOBAL MARKETS

PEDIATRIC MEDICINES: GLOBAL MARKETS PEDIATRIC MEDICINES: GLOBAL MARKETS PHM170A October 2014 Dr. Cheryl Lee Barton Project Analyst ISBN: 1-56965-971-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free

More information

Curriculum Vitae. Joachim Drevs, MD, PhD. Senior Physician 08/2002 Freiburg/Germany. Head Physician 03/2006 Freiburg/Germany

Curriculum Vitae. Joachim Drevs, MD, PhD. Senior Physician 08/2002 Freiburg/Germany. Head Physician 03/2006 Freiburg/Germany Curriculum Vitae Joachim Drevs, MD, PhD Private Address Himmelreichstrasse 15 72138 Kirchentellinsfurt Germany Phone: +49 170 1889383 Personal profile marital status: Married, 2 children age: 45 date of

More information

MSc in Toxicology. Master Degree Programme

MSc in Toxicology. Master Degree Programme Master Degree Programme MSc in Toxicology Department of Pharmaceutical Sciences, University of Basel Swiss Centre for Applied Human Toxicology (SCAHT) Master of Science in Toxicology University of Basel

More information

SIOP ACCELERATING THE DEVELOPMENT OF NEW ONCOLOGY DRUGS FOR CHILDREN AND ADOLESCENTS BRUSSELS, BELGIUM 20 21 JANUARY 2016

SIOP ACCELERATING THE DEVELOPMENT OF NEW ONCOLOGY DRUGS FOR CHILDREN AND ADOLESCENTS BRUSSELS, BELGIUM 20 21 JANUARY 2016 CDDF Cancer Drug Development Forum SIOP SIOP Europe the European Society for Paediatric Oncology CDDF-ITCC-SIOPE 4 TH ANNUAL PAEDIATRIC ONCOLOGY CONFERENCE ACCELERATING THE DEVELOPMENT OF NEW ONCOLOGY

More information

Careers in Medical and Scientific Writing

Careers in Medical and Scientific Writing Careers in Medical and Scientific Writing Laura McCormick, PhD Vice President Associate Practice Leader Tamara Fink, PhD Associate Scientific Director ProEd Communications, Inc Beachwood, Ohio Agenda Introduction

More information

EMA Update Clinical Trials

EMA Update Clinical Trials EMA Update Clinical Trials Fergus Sweeney, Head, Compliance and Inspections, European Medicines Agency 16 October 2012 An agency of the European Union Disclaimer The views presented in this presentation/these

More information

How To Design A Clinical Trial

How To Design A Clinical Trial BioBusiness BioEntrepreneurship Life Sciences Entrepreneurship BioClub BioClub BioBusiness Network at USI Clinical Trials Design and Management for Start-Up Companies LUGANO: 5-6 NOVEMBER 2012 SUPPORTED

More information

Curriculum Vitae Owner and Manager of Ad Hoc Clinical Consultant : Clinical Research Specialist

Curriculum Vitae Owner and Manager of Ad Hoc Clinical Consultant : Clinical Research Specialist Curriculum Vitae Owner and Manager of Ad Hoc Clinical Consultant : Clinical Research Specialist ID: : NANCY COTTIGNY NATIONALITY : BELGIAN YEAR OF BIRTH : 1971 GENDER : FEMALE BASED IN : IEPER, BELGIUM

More information

GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE

GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE Personal Information Date of birth July 2, 1953 Place of birth Torino, Italy Office address Department of Oncology S. Luigi Gonzaga Hospital, Oncology

More information

CURRICULUM VITAE NORBERT K. SEMMER

CURRICULUM VITAE NORBERT K. SEMMER CURRICULUM VITAE NORBERT K. SEMMER CURRENT STATUS: Full Professor of the Psychology of Work and Organizations University of Bern, Switzerland Member of the Swiss National Center of Competence in Research

More information

ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C

ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April 2015 13:10 14:20 Room C ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC Thursday 16th April 2015 13:10 14:20 Room C 1 Contents Programme.... 2 Welcome message.... 3 Faculty biographies.... 4 Symposium

More information

EU Clinical Trials Register. www.clinicaltrialsregister.eu. An agency of the European Union

EU Clinical Trials Register. www.clinicaltrialsregister.eu. An agency of the European Union EU Clinical Trials Register www.clinicaltrialsregister.eu An agency of the European Union The EU Clinical Trials Register provides public access to information from the European Union (EU) clinical trial

More information

PharmD Postdoctoral Fellowship Program

PharmD Postdoctoral Fellowship Program Novartis Institutes for Biomedical Research and Massachusetts College of Pharmacy and Health Sciences, Worcester/Manchester PharmD Postdoctoral Fellowship Program Introduction Fellowship training in the

More information

CURRICULUM VITAE. Franz Schaefer, M.D.

CURRICULUM VITAE. Franz Schaefer, M.D. CURRICULUM VITAE Franz Schaefer, M.D. ADDRESS: BORN: Center for Pediatrics and Adolescent Medicine Division of Pediatric Nephrology Im Neuenheimer Feld 430 69120 Heidelberg, Germany Phone:+49-6221-563-2396

More information

SPEAKER BIOGRAPHICAL INFORMATION

SPEAKER BIOGRAPHICAL INFORMATION SPEAKER BIOGRAPHICAL INFORMATION Madeleine R. Valera MD, MScIH (Heidelberg) Dr. Valera is a senior health care service professional with over 20 years of professional expertise in Health Financing and

More information

Medical & Surgical Devices for Children: MDUFA IV Public Meeting. July 13, 2015. Tamar Magarik Haro Associate Director Dept. of Federal Affairs

Medical & Surgical Devices for Children: MDUFA IV Public Meeting. July 13, 2015. Tamar Magarik Haro Associate Director Dept. of Federal Affairs Medical & Surgical Devices for Children: MDUFA IV Public Meeting July 13, 2015 Tamar Magarik Haro Associate Director Dept. of Federal Affairs American Academy of Pediatrics The American Academy of Pediatrics

More information

Paediatric Rheumatology InterNational Trials Organization PRINTO

Paediatric Rheumatology InterNational Trials Organization PRINTO Paediatric Rheumatology InterNational Trials Organization PRINTO Nicola Ruperto, MD, MPH PRINTO Senior Scientist EULAR Centre of Excellence in Rheumatology 2008-2013 IRCCSG Istituto G. Gaslini, Genoa,

More information

Ethical Considerations for Clinical Trials performed in Children

Ethical Considerations for Clinical Trials performed in Children Ethical Considerations for Clinical Trials performed in Children Dr. Michael Berntgen DAKJ-Workshop Berlin, 01.12.2006 Regulatory framework specifically addressing paediatric medicines Guideline ICH E11

More information

EMA policy on publication of Clinical Data. SFdS - Journée Annuelle du groupe Biopharmacie & Santé

EMA policy on publication of Clinical Data. SFdS - Journée Annuelle du groupe Biopharmacie & Santé EMA policy on publication of Clinical Data Two main objectives In the interest of public health: To enable public scrutiny - To establish trust and confidence in the system To enable application of new

More information

A Curriculum Vitae. The Differences between a Resume and a CV

A Curriculum Vitae. The Differences between a Resume and a CV A Curriculum Vitae Also called a CV or vita, the curriculum vitae is, as its name suggests, an overview of your life's accomplishments, most specifically those that are relevant to the academic realm.

More information

White Paper CLINICAL RESEARCH IN BELGIUM AN INTRODUCTION

White Paper CLINICAL RESEARCH IN BELGIUM AN INTRODUCTION White Paper CLINICAL RESEARCH IN BELGIUM AN INTRODUCTION Table of Contents 1. Introduction... 3 2. Clinical Research Activity in Belgium... 3 3. The Regulatory Landscape in Belgium... 3 4. The Healthcare

More information

THE BIOTECH & PHARMACEUTICAL INDUSTRY

THE BIOTECH & PHARMACEUTICAL INDUSTRY THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues

More information

Ethical, Practical and Regulatory Issues in Pediatric Clinical Trials

Ethical, Practical and Regulatory Issues in Pediatric Clinical Trials Member Early-bird Rate Register by October 3 and Save $95 Ethical, Practical and Regulatory Issues in Pediatric Clinical Trials October 25-26, 2005 Washington Marriott Hotel, Washington, DC, USA PROGRAM

More information

Driving improved access to treatment via Europe and through national MS Societies

Driving improved access to treatment via Europe and through national MS Societies EMSP 2014 Spring Conference Driving improved access to treatment via Europe and through national MS Societies Christoph Thalheim EMSP Luiza Wieczynska PTSR 1 The pharmaceutical industry is suffering Expiring

More information

Biotech Concerto #3. European Clinical Trial Environment

Biotech Concerto #3. European Clinical Trial Environment Biotech Concerto #3 European Clinical Trial Environment December 2008 Index EU Directive EU Approval System European Authority: EMEA The Guidance Documents Route Map Challenges EMEA Organization Chart

More information

Regulatory approval routes in the European System for Medicinal Products

Regulatory approval routes in the European System for Medicinal Products Regulatory approval routes in the European System for Medicinal Products Cardiovascular Combination Pharmacotherapy Global Summit, Melbourne, 8 th May 2014 Presented by: Kevin Blake Human Medicines Research

More information

Associate Group Director, Regulatory Intelligence & Policy

Associate Group Director, Regulatory Intelligence & Policy Date: 06/24/16 Associate Group Director, Regulatory Intelligence & Policy Job ID: 2974410847 Job Function Project Management Regulatory Affairs Location United States - District of Columbia Washington

More information

Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009

Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009 Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009 The innovative pharmaceutical industry 2 is committed to the transparency

More information

White Paper CLINICAL RESEARCH IN POLAND AN INTRODUCTION

White Paper CLINICAL RESEARCH IN POLAND AN INTRODUCTION White Paper CLINICAL RESEARCH IN POLAND AN INTRODUCTION Table of Contents 1. Healthcare Landscape in Poland... 3 2. Clinical Research Activity in Poland... 3 3. References... 6 4. About the Author... 6

More information

Pediatric Research Networks A Plan for a Collaboration in Europe. Daniela Gunz Head Clinical Trial Operations Switzerland June 9, 2011

Pediatric Research Networks A Plan for a Collaboration in Europe. Daniela Gunz Head Clinical Trial Operations Switzerland June 9, 2011 Pediatric Research Networks A Plan for a Collaboration in Europe Daniela Gunz Head Clinical Trial Operations Switzerland June 9, 2011 Agenda Challenges in clinical research in children EU pediatric regulation

More information

PhD Program in Cancer and Immunology

PhD Program in Cancer and Immunology Application Form 2010 APPLICATION DEADLINE: MAY 1ST, 2010 Please print clearly or type APPLICATION (Please, fill in with the name of the thesis director you have chosen from the list provided on our website:

More information

Dalhousie University 2014/2015 Enrolment Statistics - Enrolment by Faculty 1 and Field of Study as of December 1 (Headcounts) December 1, 2014

Dalhousie University 2014/2015 Enrolment Statistics - Enrolment by Faculty 1 and Field of Study as of December 1 (Headcounts) December 1, 2014 Dalhousie Agriculture Agricultural Business 45 4 49 49 40 9 49 49 Agricultural Economics 13 3 16 16 7 4 11 11 Agriculture 1 3 4 22 23 45 53 11 64 113 33 13 46 55 10 65 111 Animal Science 139 5 144 144

More information

BIG DATA Driving Evidence for Healthcare Thursday, 5 March 2015 13:30 17:45 Lecture Hall Pathology C

BIG DATA Driving Evidence for Healthcare Thursday, 5 March 2015 13:30 17:45 Lecture Hall Pathology C Symposium of the Swiss-Austrian ISOP Chapter International Society of Pharmacovigilance BIG DATA Driving Evidence for Healthcare Thursday, 5 March 2015 13:30 17:45 Lecture Hall Pathology C Program: Thursday,

More information

Why Are Drugs So Expensive? Learning About the Drug Development Process

Why Are Drugs So Expensive? Learning About the Drug Development Process Why Are Drugs So Expensive? Page 1 of 92 Why Are Drugs So Expensive? Learning About the Drug Development Process written by: Ann Newman Seventh Street Development Group This product is for your Personal

More information

EMA EFPIA workshop Break-out session no. 4

EMA EFPIA workshop Break-out session no. 4 EMA EFPIA workshop Break-out session no. 4 Longitudinal model-based test as primary analysis in phase III B. Bieth*, D. Renard*, I. Demin*, B. Hamrén*, G. Heimann*, Sigrid Balser** * Modeling and Simulation,

More information

EMEA RM DRAFT GUIDANCE ISPE RESPONSE 1

EMEA RM DRAFT GUIDANCE ISPE RESPONSE 1 EMEA RM DRAFT GUIDANCE ISPE RESPONSE 1 October 4, 2005 Guideline on Risk Management Systems for Medicinal Products for Human Use DRAFT London, 6 September 2005. This guideline will be included as chapter

More information

Developed by the Clinical Trial Unit at the University Hospital Basel (CTU Basel)

Developed by the Clinical Trial Unit at the University Hospital Basel (CTU Basel) Departement Klinische Forschung Clinical Trial Unit Study Handbook Diploma of Advanced Studies (DAS) in Clinical Trial Practice and Management 2014-2016 A postgraduate educational program at the Developed

More information

POSTGRADUATE CLINICAL TRAINING PROGRAMS BIOMEDICAL SCIENCES DIVISION GRADUATE PROGRAMS

POSTGRADUATE CLINICAL TRAINING PROGRAMS BIOMEDICAL SCIENCES DIVISION GRADUATE PROGRAMS 52 The student may select, with the approval of the Committee for the Clinical Component, another course among the primary areas of the Junior Internship, or in areas such as Surgery, Psychiatry, and Emergency

More information

Pharmaceutical Sciences

Pharmaceutical Sciences Is a Career in the Pharmaceutical Sciences Right for Me? Check out our online Student Center to find out more: www.aapspharmaceutica.com/students How do I know if a career in the pharmaceutical sciences

More information

Annual Report on Form 20-F

Annual Report on Form 20-F Annual Report on Form 20-F 2 Teva at a Glance Founded in 1901 by three young pharmacists, today Teva Pharmaceutical Industries Ltd. is a leader in the global pharmaceutical industry, providing medicines

More information

From Concept to a Published Paper - a guide to excellence in Medical Research.

From Concept to a Published Paper - a guide to excellence in Medical Research. The Course Directors of the New Frontiers in Interventional Cardiology (NFIC), Krakow Cardiovascular Research Institute (KCRI) and Proper Medical Writing (PMW) would like to welcome you to the seminar:

More information

298.015) UC 6:30 8:20 PM

298.015) UC 6:30 8:20 PM Course Description: This course is an in depth review of the history, authorizing statute and regulatory authority of US FDA and the influence and impact of FDA on science and health policy. Drug development,

More information

S P E C I A L I S T A N D M A S T E R S T U D I E S

S P E C I A L I S T A N D M A S T E R S T U D I E S University Ss, Cyril and Methodius Skopje FACULTY OF PHARMACY S P E C I A L I S T A N D M A S T E R S T U D I E S Healthcare management and pharmacoeconomics Skopje, 2007 STUDY PLAN -Specialist Studies-

More information

Voluntary Health Insurance: International Experience, Evidence and Prospects for the Russia Federation

Voluntary Health Insurance: International Experience, Evidence and Prospects for the Russia Federation Voluntary Health Insurance: International Experience, Evidence and Prospects for the Russia Federation Moscow June 28, 2011 The workshop will take place in Moscow on the 28 of June 2011, as part of the

More information

Courses offered by the University

Courses offered by the University 1. Ph. D. (all faculties) UNDERGRADUATE COURSES SRI RAMACHANDRA UNIVERSITY Porur, Chennai - 600 116. Courses offered by the University 2. MBBS (Bachelor of Medicine & Bachelor of Surgery) 3. BDS (Bachelor

More information

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more: www.aaps.org/forstudents

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more: www.aaps.org/forstudents Is a Career in the Pharmaceutical Sciences Right for Me? Check out our online Student Center to find out more: www.aaps.org/forstudents How Do I Know If a Career in the Pharmaceutical Sciences is Right

More information

Roche Position on Human Stem Cells

Roche Position on Human Stem Cells Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with

More information

Univ.-Prof. Dr. med. Peter Kranke, MD, PhD, MBA Consultant Anaesthetist. Curriculum vitae

Univ.-Prof. Dr. med. Peter Kranke, MD, PhD, MBA Consultant Anaesthetist. Curriculum vitae Univ.-Prof. Dr. med. Peter Kranke, MD, PhD, MBA Consultant Anaesthetist Am Ziegelbaum 11 Phone +49 (0) 931 4 04 22 01 97204 Höchberg (Germany) Fax +49 (0) 180 50 60 34 37 99 61 E-mail: peter.kranke@t-online.de

More information

Dank an Frau Tschabitscher für die Präsentation und Frau Budin für die Grafiken

Dank an Frau Tschabitscher für die Präsentation und Frau Budin für die Grafiken Dank an Frau Tschabitscher für die Präsentation und Frau Budin für die Grafiken Paediatric Regulation First experiences of a national competent authority Thanks to Mrs Tschabitscher for the slides and

More information

DR AYŞE KÜÇÜKYILMAZ. Imperial College London Personal Robotics Laboratory Department of Electrical and Electronic Engineering SW7 2BT London UK

DR AYŞE KÜÇÜKYILMAZ. Imperial College London Personal Robotics Laboratory Department of Electrical and Electronic Engineering SW7 2BT London UK DR AYŞE KÜÇÜKYILMAZ Imperial College London Personal Robotics Laboratory Department of Electrical and Electronic Engineering SW7 2BT London UK http://home.ku.edu.tr/~akucukyilmaz a.kucukyilmaz@imperial.ac.uk

More information

Vertex Investigator-Initiated Studies Program Overview

Vertex Investigator-Initiated Studies Program Overview Vertex Investigator-Initiated Studies Program Overview Our Goal To support independent, investigator-initiated research designed to advance scientific knowledge of disease states, patient populations,

More information

Orphan Drugs & Personalised Medicine: The Patient Perspective

Orphan Drugs & Personalised Medicine: The Patient Perspective Orphan Drugs & Personalised Medicine: The Patient Perspective Dr. Cees Smit, Inspire2Live/VSOP/EGAN DCTF, Ede, October 8, 2014 a Patient Advocacy Platform, bringing together patients, doctors, scientists

More information

Curriculum Vitae. Prof. Dr. Bernhard Kutscher, Ph.D. Personal Details. Education

Curriculum Vitae. Prof. Dr. Bernhard Kutscher, Ph.D. Personal Details. Education Curriculum Vitae Prof. Dr. Bernhard Kutscher, Ph.D. Personal Details Private Address: Date, Place of Birth: Marital Status: Nationality: Languages: Stresemannstraße 9, 93477 Maintal, Germany, Tel. +49

More information

ECNP Seminar, 16-18 April 2013, Suzdal, Russia

ECNP Seminar, 16-18 April 2013, Suzdal, Russia ECNP Seminar, 16-18 April 2013, Suzdal, Russia Lecturers Celso Arango Celso Arango, MD, PhD is a psychiatrist and Associate Professor of Psychiatry at the University of Maryland in Baltimore and Full Professor

More information

Moving from Compliance to Competency for the Clinical Research Professional

Moving from Compliance to Competency for the Clinical Research Professional Click to Edit Master Title Style Moving from Compliance to Competency for the Clinical Research Professional Rebecca Li, PhD, Executive Director Building A Learning Community Among Key Stakeholders - 1

More information

Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong. Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015

Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong. Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015 Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015 Clinical Trials at HKU Phase 1 Phase II Phase III Phase IV Conducted on patient

More information

Welcome to PP PHARMA PLANING This is a short Presentation of our Services

Welcome to PP PHARMA PLANING This is a short Presentation of our Services Welcome to PP PHARMA This is a short Presentation of our Services Willkommen bei PP PHARMA Bitte sehen Sie eine kurze Übersicht zu unseren Dienstleistungen International Executive Search and Specialist

More information

Overview of the EHR4CR project Electronic Health Record systems for Clinical Research

Overview of the EHR4CR project Electronic Health Record systems for Clinical Research Overview of the EHR4CR project Electronic Health Record systems for Clinical Research Dipak Kalra UCL on behalf of the EHR4CR Consortium ENCePP Plenary Meeting, 3rd May 2012, London The problem (as addressed

More information

Course Curriculum for Master Degree in Clinical Pharmacy

Course Curriculum for Master Degree in Clinical Pharmacy Course Curriculum for Master Degree in Clinical Pharmacy The Master Degree in Clinical Pharmacy is awarded by the Faculty of Graduate studies at Jordan University of Science and Technology (JUST) upon

More information

Market Access for Medical Technology & Pharmaceutical Companies An Organizational Priority in Times of Economic Austerity and Reform

Market Access for Medical Technology & Pharmaceutical Companies An Organizational Priority in Times of Economic Austerity and Reform Market Access for Medical Technology & Pharmaceutical Companies An Organizational Priority in Times of Economic Austerity and Reform By Joakim Steen Mikkelsen, Managing Healthcare Counselor, Embassy of

More information

King s College London Fees Schedule for programmes commencing in 2015/16 Postgraduate Taught

King s College London Fees Schedule for programmes commencing in 2015/16 Postgraduate Taught King s College London Fees Schedule for programmes commencing in 2015/16 Postgraduate Taught This fees schedule contains information on the programmes that King's College London intends to run in the academic

More information

THINKING WITH THE HEART: SCALING UP ACCESS TO CARDIOVASCULAR TREATMENT

THINKING WITH THE HEART: SCALING UP ACCESS TO CARDIOVASCULAR TREATMENT Pan American Forum for Action on NCDs (PAFNCD) First Forum Meeting May 9, 2012; 2:30-5:00pm Convention Center 21, Vera Cruz 2 Brasilia, Brazil THINKING WITH THE HEART: SCALING UP ACCESS TO CARDIOVASCULAR

More information

Full name/ Title of Medical Qualifications Eligible for Conditional Registration. American Board of Obstetrics and Gynaecology

Full name/ Title of Medical Qualifications Eligible for Conditional Registration. American Board of Obstetrics and Gynaecology Conferred by s in the United States of America: Board Cert (Anaesthesiology) Board Cert (Anatomic Pathology) Board Cert (Cardiology) Board Cert (Cardiovascular Disease) Board Cert (Clinical Pathology)

More information

Biometrics: Clinical Trials and Beyond

Biometrics: Clinical Trials and Beyond Biometrics: Clinical Trials and Beyond Statistics, Programming, and Data Management in Research, Development, and Regulatory Submissions. For all, Not Just Statisticians! Keynote Presentations Sue-Jane

More information

Allgemeine Rahmenbedingungen für die Entwicklung und Zulassung von Orphan Medicinal Products

Allgemeine Rahmenbedingungen für die Entwicklung und Zulassung von Orphan Medicinal Products Allgemeine Rahmenbedingungen für die Entwicklung und Zulassung von Orphan Medicinal Products PMS-Workshop Arzneimitteltherapie seltener Krankheiten Herausforderungen und Chancen Berlin-Brandenburgische

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2012) Sweden

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2012) Sweden The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe Sweden Question 1: What laws or regulations apply to an application for conducting a clinical trial in Sweden?

More information

Clinical Trials and SPA Fall, 2014

Clinical Trials and SPA Fall, 2014 Clinical Trials and SPA Fall, 2014 Laura Williams Frances Spalding Sponsored Projects Administration What to Expect Review of key clinical trial concepts A common clinical trial process How SPA fits in

More information

The Challenge of Machine Translation of Patent Specifications and the Approach of the European Patent Office

The Challenge of Machine Translation of Patent Specifications and the Approach of the European Patent Office The Challenge of Machine Translation of Patent Specifications and the Approach of the European Patent Office Georg Artelsmair Head of Department European Affairs/Member States European Patent Office Ottawa,

More information

Harmonized Core Competencies in Clinical Research: evolutions and next steps for meeting the challenge

Harmonized Core Competencies in Clinical Research: evolutions and next steps for meeting the challenge Harmonized Core Competencies in Clinical Research: evolutions and next steps for meeting the challenge Master of Applied Clinical and Preclinical Research macpr.osu.edu Consortium of Academic Programs

More information

EMA and Progressive Multifocal Leukoencephalopathy.

EMA and Progressive Multifocal Leukoencephalopathy. EMA and Progressive Multifocal Leukoencephalopathy. ENCePP Plenary, London 23 November 2011 Presented by: Henry Fitt Head of Coordination & Networking, Pharmacovigilance & Risk Management An agency of

More information

Monash University - Master of Clinical Pharmacy

Monash University - Master of Clinical Pharmacy Monash University - Master of Clinical The Master of Clinical is a 48 credit point program, equivalent to one year of full time study (generally completed in 2 years part time). It comprises 1200 hours

More information

Research on Research: Learning about Phase 1 Trials

Research on Research: Learning about Phase 1 Trials CLINICAL CASE STUDY SERIES Research on Research: Learning about Phase 1 Trials Phases of clinical trial investigation are described in some detail in the Code of Federal Regulations. Phase 1 is described

More information

CURRICULUM VITAE. (b) (6) University of Oklahoma Health Sciences Center. Director of Clinical Research Unit Department of Dermaology

CURRICULUM VITAE. (b) (6) University of Oklahoma Health Sciences Center. Director of Clinical Research Unit Department of Dermaology CURRICULUM VITAE NAME: ADDRESS: PLACE OF BIRTH: PRESENT TITLE: PREVIOUS TITLES Lynn Annette Drake, M.D. Harvard Medical School Massachusetts General Hospital 40 Blossom Street - BAR 604 Boston, MA 02114-2696

More information

October 17, 2005. Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892

October 17, 2005. Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892 October 17, 2005 Elias Zerhouni, M.D. Director National Institutes of Health One Center Drive Suite 126 MSC 0148 Bethesda, MD 20892 Dear Dr. Zerhouni: The undersigned nonprofit medical and scientific societies

More information

BioWales 2015 Pharmaceutical Supply Chain Showcase. 04 March 2015

BioWales 2015 Pharmaceutical Supply Chain Showcase. 04 March 2015 BioWales 2015 Pharmaceutical Supply Chain Showcase 04 March 2015 SIMBEC RESEARCH 40 YEARS EXPERIENCE IN EARLY STAGE CLINICAL DRUG DEVELOPMENT BACKGROUND Over 1,200 clinical studies safely and successfully

More information

Pharmacokinetics in Drug Development

Pharmacokinetics in Drug Development Pharmacokinetics in Drug Development . Peter L. Bonate Danny R. Howard Editors Pharmacokinetics in Drug Development Volume 3: Advances and Applications Editors Peter L. Bonate, Ph.D. Clinical Pharmacology,

More information

Bringing knowledge to life

Bringing knowledge to life Bringing knowledge to life High-impact content, flexible delivery informahealthcare.com Committed to Quality Content At Informa Healthcare, our mission is to connect scientists, researchers, and clinicians

More information

Nursing in Greece. Technological Education Institutes (TEI s) Take up and pursuit of the TEI course leading to nursing

Nursing in Greece. Technological Education Institutes (TEI s) Take up and pursuit of the TEI course leading to nursing Nursing in Greece Introduction Training Institutions Technological Education Institutes (TEI s) Take up and pursuit of the TEI course leading to nursing University training Take up and pursuit of the university

More information

ECRIN General Presentation

ECRIN General Presentation ECRIN General Presentation Supporting Clinical Trials Across Borders Gonzalo Calvo 26-01-16 ECRIN Overview A non-profit organisation with the legal status of European Research Infrastructure Consortium

More information

TRAINING IN SURGERY IN GREECE

TRAINING IN SURGERY IN GREECE TRAINING IN SURGERY IN GREECE George N Zografos Consultant Surgeon, Athens General Hospital General Secretary Hellenic Surgical Association National Delegate, UEMS Division of General Surgery STATISTICAL

More information

Analysis of EU PhD Education and Research. Prof. Dr. Hans G. Sonntag, MF Heidelberg

Analysis of EU PhD Education and Research. Prof. Dr. Hans G. Sonntag, MF Heidelberg Analysis of EU PhD Education and Research Prof. Dr. Hans G. Sonntag, MF Heidelberg History of Doctoral Degrees Doctoral degrees as old as universities Universities had the permission to award doctoral

More information

de formation continue Diploma of Advanced Studies Management of Clinical Trials Good Clinical Practice Implementation and Quality Processes

de formation continue Diploma of Advanced Studies Management of Clinical Trials Good Clinical Practice Implementation and Quality Processes DAS Diplôme de formation continue Diploma of Advanced Studies Management of Clinical Trials Good Clinical Practice Implementation and Quality Processes October 2015 September 2016 CRC Centre de Recherche

More information

DR AYŞE KÜÇÜKYILMAZ. Yeditepe University Department of Computer Engineering Kayışdağı Caddesi 34755 Istanbul Turkey

DR AYŞE KÜÇÜKYILMAZ. Yeditepe University Department of Computer Engineering Kayışdağı Caddesi 34755 Istanbul Turkey DR AYŞE KÜÇÜKYILMAZ Yeditepe University Department of Computer Engineering Kayışdağı Caddesi 34755 Istanbul Turkey http://cse.yeditepe.edu.tr/~akucukyilmaz akucukyilmaz@cse.yeditepe.edu.tr QUALIFICATIONS

More information

History and Principles of Good Clinical Practice

History and Principles of Good Clinical Practice History and Principles of Good Clinical Practice Cristina E. Torres, Ph.D. Social Science Professor, UPM-NIH FERCAP Coordinator ICH: International Conference on Harmonization GCP: Good Clinical Practices

More information

Future roles and opportunities for statisticians in pharmaceutical industry

Future roles and opportunities for statisticians in pharmaceutical industry Future roles and opportunities for statisticians in pharmaceutical industry H. Ulrich Burger 1), Stefan Driessen 2), Chrissie Fletcher 3), Michael Branson 4), Christoph Gerlinger 5) 1) Hoffmann-La Roche

More information

SEARCH The Health Sciences Library Manipal University, Manipal. Library e-resources

SEARCH The Health Sciences Library Manipal University, Manipal. Library e-resources SEARCH The Health Sciences Library Manipal University, Manipal Library e-resources SEARCH - The Health Sciences Library provides access to the following e-resources (online full text databases, online

More information

Clinical Research Infrastructure at the European level: the ECRIN model. Christine Kubiak ECRIN Coordination Inserm- DRCT

Clinical Research Infrastructure at the European level: the ECRIN model. Christine Kubiak ECRIN Coordination Inserm- DRCT Clinical Research Infrastructure at the European level: the RIN model Christine Kubiak RIN Coordination Inserm- DRCT Finland FinnCRIN Ireland ICRIN UK UKCRN France Inserm Denmark DCRIN Germany KKS Switzerland

More information

Our name ASPHALION derives from the Greek word asphaléia, alluding to values such as firmness, stability, certainty and reliability.

Our name ASPHALION derives from the Greek word asphaléia, alluding to values such as firmness, stability, certainty and reliability. Company Profile Our History ASPHALION is an International Drug Development and Regulatory Affairs consultancy firm founded in 2000, with an international team of over 40 people. Our Values Our name ASPHALION

More information

Transparency in Animal Research: Implementing Openness in Publication and Communication London, July 1 2 2013

Transparency in Animal Research: Implementing Openness in Publication and Communication London, July 1 2 2013 Transparency in Animal Research: Implementing Openness in Publication and Communication London, July 1 2 2013 Venue: Co-Chairs: 30 Euston Square/Royal College of General Practitioners, Camden Town, London,

More information

SWEDISH CANDIDATURE FOR UEMO NEXT PRESIDENCY

SWEDISH CANDIDATURE FOR UEMO NEXT PRESIDENCY EUROPEAN UNION OF GENERAL PRACTITIONERS Alment Praktiserende Lægers Europæiske Organisation UEMO European Union of General Practitioners UEMO Europäische Vereingung der Allgemeinärzte UEMO Union Européenne

More information

DR. MICHAEL FRENKEL PROFESSOR OF ECONOMICS

DR. MICHAEL FRENKEL PROFESSOR OF ECONOMICS DR. MICHAEL FRENKEL PROFESSOR OF ECONOMICS CURRICULUM VITAE Office: Chair of Macroeconomics and International Economics WHU Otto Beisheim School of Management Burgplatz 2 56179 Vallendar, Germany Tel.:

More information

BioMed Partners. The rocky way from science to market. Dr. Karsten Fischer BioMedPartners AG. VPM Days Hannover

BioMed Partners. The rocky way from science to market. Dr. Karsten Fischer BioMedPartners AG. VPM Days Hannover The rocky way from science to market Dr. Karsten Fischer BioMedPartners AG VPM Days Hannover November 2013 Content I. Stage 1 II. Setbacks 6 III. Hope 12 IV. Solutions 17 V. Expertise 20 Page 1 The Challenge

More information

Extemporaneously Prepared Early Phase Clinical Trial Materials

Extemporaneously Prepared Early Phase Clinical Trial Materials Extemporaneously Prepared Early Phase Clinical Trial Materials Richard Hoffman, MS, RAC Eli Lilly & Co. Regulatory Advisor International Consortium for Innovation & Quality in Pharmaceutical Development

More information

Northeast Ohio Medical University (NEOMED) Chair of Pharmaceutical Sciences Search

Northeast Ohio Medical University (NEOMED) Chair of Pharmaceutical Sciences Search Northeast Ohio Medical University (NEOMED) Chair of Pharmaceutical Sciences Search Spring 2013 About NEOMED Northeast Ohio Medical University (NEOMED) www.neomed.edu is a dynamic free-standing community-based,

More information

CURRICULUM VITAE. Paul Magnus Schneider, M.D. Professor of Surgery

CURRICULUM VITAE. Paul Magnus Schneider, M.D. Professor of Surgery CURRICULUM VITAE Paul Magnus Schneider, M.D. Professor of Surgery OFFICE Department of Visceral and Transplantation Surgery University Hospital Zurich CH-8008 Zurich Switzerland phone: +41-(0)44-2559723

More information

GLENDA M. GUEST, BS, CCRA, RQAP-GCP gmg@ncra.com 607-334-5850. Norwich Clinical Research Associates Ltd.

GLENDA M. GUEST, BS, CCRA, RQAP-GCP gmg@ncra.com 607-334-5850. Norwich Clinical Research Associates Ltd. GLENDA M. GUEST, BS, CCRA, RQAP-GCP gmg@ncra.com 607-334-5850 WORK EXPERIENCE Norwich Clinical Research Associates Ltd. Vice-President Vice-Chair of the Board of Directors Director of Marketing 1998 present

More information